You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

15 Results
Guidelines and Advice
Guidelines and Advice
Feb 2024
Guidelines and Advice
Guidelines and Advice
Guidelines and Advice
Status: Archived
ID: 13-1
Aug 2003
Guidelines and Advice
Statistical Reports
Drug
Other Name(s): Zometa®
Feb 2024
Drug
Feb 2024
Regimen
Intent: Palliative
Funding:
ODB - General Benefit
    fulvestrant
Feb 2024
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Intent: Curative
Feb 2024

Pages